About Mathym
Mathym is a company based in Ecully (France) founded in 2013 was acquired by Baikowski in September 2019.. Mathym has raised $2.43 million across 2 funding rounds from investors including Baikowski, Octalfa and Kreaxi. Mathym offers products and services including zilight® nano-zirconia, filyxio® nano-YbF₃, nano-CeO₂, and Custom materials. Mathym operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Ecully, France
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mathym
Mathym offers a comprehensive portfolio of products and services, including zilight® nano-zirconia, filyxio® nano-YbF₃, nano-CeO₂, and Custom materials. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-performing material for optics and photonics applications.
Nanomaterial used in dental and semiconductor manufacturing.
Dispersions for solid state lighting and industrial uses.
Tailored dispersions for specific R&D and market needs.
Funding Insights of Mathym
Mathym has successfully raised a total of $2.43M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.43 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $2.4M
-
First Round
First Round
(01 Jan 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Series A - Mathym | Valuation |
investors |
|
| Jan, 2016 | Amount | Grant - Mathym | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mathym
Mathym has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Baikowski, Octalfa and Kreaxi. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Octalfa is engaged in creating and supporting innovative companies.
|
Founded Year | Domain | Location | |
|
Kreaxi is engaged in equity financing for innovative startups.
|
Founded Year | Domain | Location | |
|
Alumina powders and formulations are manufactured for industrial uses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mathym
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mathym
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mathym Comparisons
Competitors of Mathym
Mathym operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mathym
Frequently Asked Questions about Mathym
When was Mathym founded?
Mathym was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Where is Mathym located?
Mathym is headquartered in Ecully, France. It is registered at Ecully, Auvergne-rhone-alpes, France.
Who is the current CEO of Mathym?
Julien Alberici is the current CEO of Mathym.
Is Mathym a funded company?
Mathym is a funded company, having raised a total of $2.43M across 2 funding rounds to date. The company's 1st funding round was a Grant of $292.2K, raised on Jan 01, 2016.
What does Mathym do?
Mathym was established in 2013 in Ecully, France, as a nanotechnology firm. Nanomaterials are developed, manufactured, and commercialized in colloidal solution form. Emphasis is placed on life science sectors, including medical devices. Industrial partners are supplied with compatible nano-dispersions that integrate critical properties without risk. Operations focus on providing fully tested dispersions for device enhancement.
Who are the top competitors of Mathym?
Mathym's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Mathym offer?
Mathym offers zilight® nano-zirconia, filyxio® nano-YbF₃, nano-CeO₂, and Custom materials.